MENADNA Inc., has entered into an exclusive partnership with ProPhase Labs' subsidiary, Nebula Genomics, aiming to advance genomic testing in Jordan, Oman, and Iraq. This collaboration will leverage Nebula Genomics' advanced sequencing technologies and MENADNA's bioinformatics capabilities to improve the quality and relevance of genomic data in these historically underserved regions. Pleasanton, CA -- MENADNA [...]

GLENDALE HEIGHTS, Ill. -- Ampersand Capital Partners ("Ampersand"), a private equity firm specializing in growth equity investments in the life sciences and healthcare sectors, announced today the acquisition of Biologos LLC ("Biologos"), a full-service manufacturer of custom and standard cell culture media, reagents, buffers, enzymes, and sera. The partnership with Ampersand will include investments to expand Biologos' [...]

Cambridge, UK – SPT Labtech, a global leader in the design, development and manufacture of automated instrumentation and consumables for life science applications, announces its co-marketing collaboration with Roche to deliver a streamlined method for Illumina-compatible Next Generation Sequencing (NGS) library preparation. By leveraging SPT Labtech’s all-in-one automated liquid handling platform, firefly®, this collaboration offers [...]

Nuclera recognized as one of UK’s most exciting growth stage companies Official launch of 2024 cohort taken place at 10 Downing Street Cambridge, UK: Nuclera, the biotechnology company enabling rapid protein expression and purification screening through its eProtein Discovery benchtop protein platform, today announced it has been selected to join the Tech Nation Future Fifty 2024 [...]

Experienced executive with extensive background as CFO for global corporations across dynamic sectors Cytek reaffirms 2024 outlook FREMONT, Calif. -- Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced that William (Bill) McCombe has been appointed chief financial officer of the company effective immediately. McCombe brings experience as a public company CFO at both large scale, and [...]

WALTHAM, Mass. -- Repligen Corporation (NASDAQ:RGEN) today announced the appointment to its Board of Directors of life sciences industry executive Maggie A. Pax. This appointment expands the size of Repligen’s board from eight to nine members. Ms. Pax brings to Repligen over 25 years of experience leading the development and execution of growth strategies for [...]

CAMBRIDGE, Mass. – Data-driven laboratory and manufacturing operational connectivity pioneer Elemental Machines announced the addition of Rob Estrella as its new SVP of Global Sales. Estrella joined Elemental Machines to support their continued and deep commitment to serving the life sciences market and growth of enterprise-level Internet of Things (IoT) technology across laboratory and manufacturing spaces. Elemental Machines is [...]

Bringing End-to-End Spatial Biology Solutions to Life Sciences Researchers for Advanced Spatial Proteomics Analysis WALTHAM, Mass. --  BostonGene, a leading provider of AI-driven molecular and immune profiling solutions, announced today that it has been named as a qualified contract research organization (CRO) of Akoya Biosciences (Nasdaq: AKYA; “Akoya”). By combining Akoya's single-cell imaging solutions with BostonGene's unparalleled [...]

Proceeds support continued development and commercialization of cell engineering platform technology across research and clinical applications. Over 20 active partners to date, ranging from large pharmaceutical and biotechnology companies to leading academic institutions. CAMBRIDGE, Mass. -- Today, Portal Biotechnologies, Inc. ("Portal"), a cell engineering platform company, announced a $5M pre-seed round led by Pear VC, [...]

As of the 1st of April 2024, MyBio Ltd. will be the main point of contact for sales and supply of QIAGEN’s world leading “Sample to Insight” solutions for life science customers throughout the island of Ireland.  MyBio's Founder & CEO, Linda Nolan is delighted to announce this new exclusive partnership with QIAGEN to distribute their Life Science research product portfolio throughout [...]